Wilhelmus Cm Groenhuysen, Chief Operating Officer at NovoCure Ltd (NVCR), sold 51,270 shares at $76.16 ($3.9M) on 2023-03-03, disclosed to the SEC on 2023-03-07.
Seasonal sale ($3.9M) by Chief Operating Officer — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.16 | 1,692 | $129K | 3.3% |
| 2 | $76.16 | 1,692 | $129K | 3.3% |
| 3 | $76.16 | 3,528 | $269K | 6.9% |
| 4 | $76.16 | 3,528 | $269K | 6.9% |
| 5 | $76.16 | 20,415 | $1.6M | 39.8% |
| 6 | $76.16 | 20,415 |
| $1.6M |
| 39.8% |
| Total | $76.16 avg | 51,270 | $3.9M | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $330K | — | Filing → |